Entity tied to ESTA director sells 37,500 shares

Rhea-AI Filing Summary

Establishment Labs Holdings Inc. director-related entity Sariel Group Ltd sold 37,500 Common Shares of ESTA on April 14, 2026 in an open‑market transaction at a weighted average price of $65.228 per share, within a range of $65.00 to $65.60, under a pre‑arranged Rule 10b5-1 trading plan.

Following the sale, Sariel Group Ltd held 1,182,504 Common Shares indirectly attributable to director Juan Jose Chacon Quiros, while he also held 45,193 Common Shares directly. He disclaims beneficial ownership of Sariel Group Ltd’s shares except to the extent of his pecuniary interest.

Insider Trade Summary

Net Seller: 37,500 shares

Net Sell 2 txns

Insider Chacon Quiros Juan Jose

Role Director

Sold 37,500 shs ($2.45M)

Type	Security	Shares	Price	Value
Sale	Common Shares	37,500	$65.228	$2.45M
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 1,182,504 shares (Indirect, See Footnote); Common Shares — 45,193 shares (Direct)

Footnotes (3)

1. F1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. F2. This transaction was executed in multiple trades at prices ranging from $65.00 to $65.60 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3. F3. The shares are held by Sariel Group Ltd. The Reporting Person is a shareholder of Sariel Group Ltd and has voting and dispositive power over the shares owned by Sariel Group Ltd. The Reporting Person disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein.

Key Figures

Shares sold: 37,500 shares Weighted average sale price: $65.228 per share Sale price range: $65.00–$65.60 per share +2 more

5 metrics

Shares sold 37,500 shares Open-market sale on April 14, 2026

Weighted average sale price $65.228 per share Common Shares sold April 14, 2026

Sale price range $65.00–$65.60 per share Multiple trades comprising the 37,500-share sale

Indirect shares after sale 1,182,504 shares Common Shares held by Sariel Group Ltd after transaction

Direct shares after transaction 45,193 shares Common Shares directly held by Juan Jose Chacon Quiros

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, pecuniary interest, voting and dispositive power

4 terms

Rule 10b5-1 trading plan regulatory

"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

pecuniary interest financial

"disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein."

voting and dispositive power regulatory

"has voting and dispositive power over the shares owned by Sariel Group Ltd."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale did Establishment Labs (ESTA) report in this Form 4?

An entity linked to director Juan Jose Chacon Quiros sold 37,500 Establishment Labs common shares. The sale occurred on April 14, 2026 at a weighted average price of $65.228 per share, in open‑market trades within a $65.00 to $65.60 price range.

Who actually sold the ESTABLISHMENT LABS (ESTA) shares in this filing?

The shares were sold by Sariel Group Ltd, an entity associated with director Juan Jose Chacon Quiros. He is a shareholder of Sariel Group Ltd and has voting and dispositive power over its shares but disclaims beneficial ownership except for his pecuniary interest.

Was the Establishment Labs (ESTA) insider sale made under a Rule 10b5-1 plan?

Yes, the sale was executed under a pre‑arranged Rule 10b5-1 trading plan adopted by the reporting person. Such plans schedule trades in advance, which can make the timing of sales appear more routine and less discretionary for the insider.

How many Establishment Labs (ESTA) shares does the related entity hold after the sale?

After selling 37,500 shares, Sariel Group Ltd held 1,182,504 Establishment Labs common shares. These are reported as indirectly owned by director Juan Jose Chacon Quiros, reflecting his relationship to the entity and his voting and dispositive power over its holdings.

What are Juan Jose Chacon Quiros’s direct Establishment Labs (ESTA) holdings after this Form 4?

Following the reported transactions, Juan Jose Chacon Quiros directly held 45,193 Establishment Labs common shares. This direct position is separate from the 1,182,504 shares held indirectly through Sariel Group Ltd, which are reported with a beneficial ownership disclaimer.

At what prices were the Establishment Labs (ESTA) shares sold in this insider transaction?

The 37,500 Establishment Labs shares were sold in multiple trades at prices between $65.00 and $65.60 per share. The Form 4 reports a weighted average sale price of $65.228 per share and notes that full trade‑by‑trade details are available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chacon Quiros Juan Jose

(Last) (First) (Middle)

C/O MOTIVA USA LLC

16192 COASTAL HIGHWAY

(Street)

LEWES DELAWARE 19958

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ESTABLISHMENT LABS HOLDINGS INC. [ ESTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/14/2026		S(1)		37,500	D	$65.228(2)	1,182,504	I	See Footnote(3)
Common Shares								45,193	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

2. This transaction was executed in multiple trades at prices ranging from $65.00 to $65.60 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

3. The shares are held by Sariel Group Ltd. The Reporting Person is a shareholder of Sariel Group Ltd and has voting and dispositive power over the shares owned by Sariel Group Ltd. The Reporting Person disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Juan Jose Chacon Quiros	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)